Skip to content

Clinical trials

Phase 2 Drug-Related Side Effects and Adverse Reactions trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Drug-Related Side Effects and Adverse Reactions Phase: Phase 2 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20202
20212
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anhui Medical University2
Peking University People's Hospital2
Anhui Provincial Hospital1
CSPC Ouyi Pharmaceutical Co., Ltd.1
Eli Lilly and Company1
Lei Li1
Southern China Urology Cancer Consortium1
Zhejiang Cancer Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Drug-Related Side Effects and Adverse Reactions10
Osteosarcoma2
Carcinoma, Renal Cell1
Esophageal Squamous Cell Carcinoma1
Nausea1
Neoplasms1
Stomach Neoplasms1
Uterine Cervical Neoplasms1
Vomiting1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.